Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    23553119 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
Condition: Actinic Keratosis
Intervention: Drug: Lesion count
2 Completed A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Condition: Actinic Keratosis
Intervention: Drug: Lesion count
3 Completed A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
Condition: Actinic Keratosis
Intervention: Drug: Lesion count
4 Completed Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: ingenol mebutate gel 0.015%;   Drug: ingenol mebutate gel 0.05%

Study has passed its completion date and status has not been verified in more than two years.